Challenges in Managing Increasing Infection Rates in Cirrhosis
The natural history of cirrhosis is significantly affected by the increasing prevalence of infections, with strategies for prevention and treatment difficult to compose.
Hepatology
Sleep-Wake Disturbance Highly Prevalent in Populations With Liver Disease
Researchers summarized the reciprocal interaction between sleep and liver diseases, including cirrhosis, and investigated potential approaches for therapeutic interventions.
Epstein-Barr Virus: Forgotten Etiology of Hepatic Injury
Epstein-Barr virus infection may present with liver injury characterized by acute cholestatic hepatitis, as demonstrated in this case.
Pharmacotherapies for Liver Fibrosis, NASH Resolution Ranked
Although NASH is a common cause of chronic liver disease, there is limited evidence surrounding its management.
Better Strategies Needed for Managing NAFLD in Adults
Needs assessment survey conducted in response to increasing clinical burden of nonalcoholic fatty liver disease, nonalcoholic steatohepatitis
Opioid Agonist Therapy Linked to Increased HCV Treatment Rates in People Who Inject Drugs
Researchers studied the impact of current opioid agonist therapy on initiation of chronic hepatitis C virus treatment among a population of individuals who inject drugs.
Acute-on-Chronic Liver Failure: Comparing First-Line Antivirals in Chronic HBV
Investigators conducted an ongoing prospective cohort study to better understand the safety and efficacy of nucleoside and/or nucleotide analogs among patients with hepatitis B virus-related acute-on-chronic liver failure.
Seroclearance of Hepatitis B Surface Antigens by 10 Years Rare After Antiviral Therapies
Investigators estimated the incidence of HBsAg seroclearance in patients with hepatitis B virus infection on long-term therapy with entecavir or tenofovir disoproxil fumarate.
Hepatitis B Virus Monitoring Needed After Liver Transplantation
While the risk is small, there have been 20 cases of unexpected donor-derived hepatitis B virus infection
HBV Suppression Lowers Liver Cancer Rates in Patients Coinfected With HIV
Findings emphasize the importance of strategies to help HBV-HIV coinfected patients maximize antiretroviral adherence to achieve hepatitis B viral suppression.
- Loading...
Loading...
Next post in Infectious Diseases Information Center
Loading... 
Loading...